info@imgenexindia.com
0674-6544312
Loading...
  • CUSTOM ANTIBODY DEVELOPMENT
    CUSTOM ANTIBODY DEVELOPMENT
    Custom Antibody
    Development
    Small to large scale purification
    Conjugation services
    Performance testing
  • STABLE CELL LINE DEVELOPMENT
    STABLE CELL LINE DEVELOPMENT
    Gene optimization
    Assay development
    Sub-cloning and storage
    Stable Cell Line
    Development
  • PROTEIN PRODUCTION
    PROTEIN PRODUCTION
    Small scale to 1 gram quantities
    Gene optimization
    Baculovirus, bacterial & mammalian cell systems
    Protein Production
  • DRUG DISCOVERY SCREENING SERVICES
    DRUG DISCOVERY SCREENING SERVICES
    Drug Discovery
    Screening Services
    Compound screening
    Hit identification
    Lead optimization
    Target reporter assays
    Functional cell assays
  • Protein Lounge Services
    Custom Biosimilar
    Product Development
    More Than Just a Service
    Accelerated Biosimilars Product Development
    End-to-End Services in Development

How we are different

At IMGENEX INDIA, we realize you have many options for your out-of-lab research support. Our difference is simple- we treat your research as if it were our own. We listen to you, and we will tell you what we can (and what we cannot) do for you to your 100% satisfaction. Consider IMGENEX INDIA for our cost-effective alternative to other providers.

 

  • Low minimum order requirements : allow us to assist in your small scale and proof-of-concept experiments without a lot of out of pocket expense.
  • Cost flexibility : we recognize the need for maximizing your research budget and can offer your lab the services you need at the price you want. Talk with us about our New Business pricing for starting your new venture and project with us.

 

 

News

  • IMGENEX INDIA Pvt. Ltd. has been awarded as an Emerging Company of the Year 2015 under Bio Industrial category in India. [details]
  • IMGENEX INDIA in collaboration with Indian Agricultural Research Institute, New Delhi has been awarded a grant from BIRAC to develop detection kit for plant viruses.
  • IMGENEX INDIA has been awarded a 3-year Phase II grant under the BIRAC scheme, Government of India to develop biosimilar Herceptin for the treatment of breast cancer.
    MORE NEWS